Cart
sales@molnova.com
NSC-109555 ditosylate
CAS No. 66748-43-4
NSC-109555 ditosylate( DDUG | NSC109555 | NSC 109555 )
Catalog No. M15549 CAS No. 66748-43-4
A potent, selective, reversible, ATP-competitive Chk2 inhibitor with IC50 of 0.2 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNSC-109555 ditosylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, reversible, ATP-competitive Chk2 inhibitor with IC50 of 0.2 uM.
-
DescriptionA potent, selective, reversible, ATP-competitive Chk2 inhibitor with IC50 of 0.2 uM; displays no effect on a range of other kinases including Chk1 (IC50>10 uM); inhibits histone H1 phosphorylation (IC50=0.24 uM) and attenuates mitochondrial ATP synthesis; exhibits antiproliferative activity in a number of leukemias in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsDDUG | NSC109555 | NSC 109555
-
PathwayAngiogenesis
-
TargetChk
-
RecptorChk
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66748-43-4
-
Formula Weight752.86
-
Molecular FormulaC19H24N10O.2C7H8O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(/C(C)=N/N=C(N)/N)C=C1)NC2=CC=C(/C(C)=N/N=C(N)/N)C=C2.OS(=O)(C3=CC=C(C)C=C3)=O.OS(=O)(C4=CC=C(C)C=C4)=O
-
Chemical Name4,4'-diacetyldiphenylurea bis(guanylhydrazone) ditosylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jobson AG, et al. Mol Pharmacol. 2007 Oct; 72(4):876-84.
2. Gogineni VR, et al. Cancer Lett. 2011 Dec 26;313(1):64-75.
3. Mikles-Robertson F, et al. Cancer Res. 1980 Apr;40(4):1054-61.
molnova catalog
related products
-
VRX-0466617
A potent and selective Chk2 inhibitor with Ki/IC50 of 11 nM/120 nM; shows no inhibitory effect on Chk1 (>100 uM).
-
GDC0575 monohydrochl...
GDC-0575 is a potent and selective inhibitor of cell cycle checkpoint kinase 1 (Chk1) with an IC50 of 1.2?nM. GDC-0575 specifically binds to and inhibits Chk1; this may result in tumor cells bypassing Chk1-dependent cell cycle arrest in the S and G2/M phases, which permits the cells to undergo DNA repair prior to entry into mitosis.
-
Baricitinib
Baricitinib (LY3009104, INCB028050) is a selective JAK1 and JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM in cell-free assays.
